Form 4 for INSM INSMED Inc
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001628280-24-025894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-30 | 2024-05-28 | INSM | Smith Michael Alexander | CLO | M - OptEx | $14.27 | +39.0K | 111.6K | +54% | +$556.1K |
| D | 2024-05-30 | 2024-05-28 | INSM | Smith Michael Alexander | CLO | S - Sale+OE | $49.53 | -44.7K | 88.8K | -33% | -$2.22M |
| DM | 2024-05-30 | 2024-05-28 | INSM | Smith Michael Alexander | CLO | M - OptEx | $0.00 | -39.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 3,691 | $10.85 | 115,270 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-28 | M | A | 3,470 | $11.38 | 118,740 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-28 | M | A | 14,810 | $13.67 | 133,550 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-28 | S | D | 44,722 | $49.53 | 88,828 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-28 | M | A | 7,000 | $16.07 | 101,579 | D | — | — | |
| 6 | Common | Common Stock | 2024-05-28 | M | A | 10,000 | $16.16 | 111,579 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,691 | $0.00 | 0 | D | $10.85 · — to 2026-05-19 | 3,691 Common Stock | (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 3,470 | $0.00 | 0 | D | $11.38 · — to 2026-08-02 | 3,470 Common Stock | (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 14,810 | $0.00 | 0 | D | $13.67 · — to 2027-01-05 | 14,810 Common Stock | (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 10 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 7,000 | $0.00 | 0 | D | $16.07 · — to 2025-01-08 | 7,000 Common Stock | (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 11 | Derivative | Stock Option (right to buy) | 2024-05-28 | M | D | 10,000 | $0.00 | 0 | D | $16.16 · — to 2026-01-07 | 10,000 Common Stock | (F2) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |